Chemoinformaics analysis of Conessimine/Isoconessimine
| Molecular Weight | 342.571 | nRot | 1 |
| Heavy Atom Molecular Weight | 304.267 | nRig | 24 |
| Exact Molecular Weight | 342.303 | nRing | 5 |
| Solubility: LogS | -3.855 | nHRing | 1 |
| Solubility: LogP | 4.329 | No. of Aliphatic Rings | 5 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 2 | No. of Aliphatic Carbocycles Rings | 4 |
| Atoms Count | 63 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 25 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 3 |
| No. of Hydrogen atom | 38 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 23 | No. of Saturated Rings | 4 |
| No. of Nitrogen atom | 2 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 65.9481 |
| nHD | 1 | BPOL | 40.4019 |
| QED | 0.707 |
| Synth | 4.984 |
| Natural Product Likeliness | 2.615 |
| NR-PPAR-gamma | 0.004 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0 |
| Pgp-sub | 0 |
| HIA | 0.016 |
| CACO-2 | -4.788 |
| MDCK | 0.00000458 |
| BBB | 0.453 |
| PPB | 0.612286 |
| VDSS | 1.363 |
| FU | 0.380572 |
| CYP1A2-inh | 0.037 |
| CYP1A2-sub | 0.33 |
| CYP2c19-inh | 0.027 |
| CYP2c19-sub | 0.98 |
| CYP2c9-inh | 0.025 |
| CYP2c9-sub | 0.042 |
| CYP2d6-inh | 0.927 |
| CYP2d6-sub | 0.927 |
| CYP3a4-inh | 0.113 |
| CYP3a4-sub | 0.796 |
| CL | 17.39 |
| T12 | 0.035 |
| hERG | 0.128 |
| Ames | 0.023 |
| ROA | 0.264 |
| SkinSen | 0.045 |
| Carcinogencity | 0.235 |
| EI | 0.005 |
| Respiratory | 0.982 |
| NR-Aromatase | 0.002 |
| Antiviral | No |
| Prediction | 0.702903 |